Plasma chitotriosidase in health and pathology

Clinical Laboratory

Volumn 53, Issue 5-6, 2007, Pages 321-333

  Barone, Rita ^a   Sotgiu, Stefano ^b   Musumeci, Salvatore ^b  

^a CNR   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Alzheimer's disease; Chitotriosidase; Gaucher's disease; Malaria; Multiple sclerosis; Stroke; Thalassemia

Indexed keywords

ALGLUCERASE; AMYLOID BETA PROTEIN; ATORVASTATIN; BEZAFIBRATE; CHITOTRIOSIDASE; FERRITIN; GLUCOSAMINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; ANOPHELES; ATHEROSCLEROSIS; BETA THALASSEMIA; CEREBROVASCULAR ACCIDENT; CHROMOSOME 1Q; ENZYME ACTIVITY; ENZYME REPLACEMENT; FERRITIN BLOOD LEVEL; FILARIASIS; GAUCHER DISEASE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEMATOLOGIC DISEASE; HOMOZYGOTE; HUMAN; HYPERLIPIDEMIA; INFECTION RISK; INNATE IMMUNITY; IRON OVERLOAD; MACROPHAGE ACTIVATION; MALARIA; MULTIPLE SCLEROSIS; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW;

AGING; ALZHEIMER DISEASE; GAUCHER DISEASE; HEXOSAMINIDASES; HUMANS; IMMUNITY, NATURAL; MALARIA; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; STROKE; THALASSEMIA;

FUNGI; MAMMALIA;

EID: 34250868469     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Hollak CE, Van Weely S, Van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher's disease. J Clin Invest 1994;93:1288-92.
2. Renkema GH, Boot RG, Strijland A et al. Synthesis, sorting and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem 1997;244:279-85.
3. Renkema GH, Boot RG, An FL et al. Chitotriosidase, a chitinase and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1998;251:504-9.
4. Den Tandt WR, Van Hoof F. Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher's disease patients. J Inher Metab Dis 1996;19: 344-50.
5. Young E, Chatterton C, Vellodi A, Winchester B. Plasma chitotriosidase activity in Gaucher's disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with alglucerase. J Inher Metab Dis 1997; 20: 595-602.
6. Vedder AC, Cox-Brinkman J, Hollak CE, Linthorst GE, Groener JE, Helmond MT, Scheij S, Aerts JM. Plasma chitotriosidase in male Fabry patients: A marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy. Mol Genet Metab. 2006; 89(3):239-44.
7. Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, Mannens MM, Aerts JM.The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998;273:25680-5.
8. Bouzas L, Carlos Gumarte J, Carlos Tutor J. Chitotriosidase activity in plasma and mononuclear and polymorphonuclear leukocyte populations. J Clin Lab Anal. 2003;17:271-5.
9. Bierbaum S, Superti-Furga A, Heinzmann A. Genetic polymorphisms of chitotriosidase in Caucasian children with bronchial asthma. Int J Immunogenet. 2006; 33:201-4.
10. Bierbaum S, Nickel R, Koch A, Lau S, Deichmann KA, Walm U, Superti-Furga A, Heinzmarm A. Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med. 2005;172:1505-9.
11. Gianfrancesco F, Musumeci S. The evolutionary conservation of the human chitotriosidase gene in rodents and primates. Cytogenet Genome Res. 2004;105:54-6.
12. Boot RG, Bussink AP, Verhoek M, de Boer PA, Moorman AF, Aerts JM. Marked differences in tissue-specific expression of chitinases in mouse and man. J Histochem Cytochem. 2005; 53:1283-92
13. Malaguarnera L, Simpore J, Prodi DA, Angius A, Sassu A, Persico I, Barone R, Musumeci S. A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun. 2003;4:570-4.
14. Canudas J, Cenarro A, Civeira F, Garci-Otin AL, Aristegui R, Diaz C, Masramon X, Sol JM, Hernandez G, Pocovi M. Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism 2001;50:447-50.
15. Choi EH, Zimmerman PA, Foster CB, Zhu S, Kumaraswami V, Nutman TB, Chanock SJ. Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun 2001;2:248-53.
16. Musumeci M, Malaguarnera L, Simpore J, Barone R, Whalen M, Musumeci S. Chitotriosidase activity in colostrum from African and Caucasian women. Clin Chem Lab Med. 2005;43:198-201.
17. Labadaridis J, Dimitriou E, Costalos C, Aerts J, van Weely S, Donker-Koopman WE, Michelakakis H. Serial chitotriosidase activity estimations in neonatal systemic candidiasis. Acta Paediatr. 1998;87(5):605.
18. Labadaridis I, Dimitriou E, Theodorakis M, Kafalidis G, Velegraki A, Michelakakis H. Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child Fetal Neonatal Ed. 2005;90:F531-2.
19. van Eijk M, van Roomen CP, Renkema GH, Bussink AP, Andrews L, Blommaart EF, Sugar A, Verhoeven AJ, Boot RG, Aerts JM. Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol. 2005; 17:1505-12.
20. Masoud M, Rudensky B, Elstein D, Zimran A. Chitotriosidase deficiency in survivors of Candida sepsis. Blood Cells Mol Dis. 2002;29:116-8.
21. Barone I, Bertrand G, Simpore J, Malaguarnera M, Musumeci S. Plasma chitotriosidase activity in beta-thalassemia major: a comparative study between Sicilian and Sardinian patients. Clin Chim Acta. 2001;306:91-6.
22. Barone R, Malaguarnera L, Angius A, Musumeci S. Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol. 2003;72:285-6.
23. Maccarone C, Pizzarelli G, Barone R, Musumeci S. Plasma chitotriosidase activity is a marker of recovery in transplanted patients affected by beta-thalassemia major. Acta Haematol. 2001;105:109-10.
24. Barone R, Simpore J, Malaguarnera L, Pignatelli S, Musumeci S. Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin Chim Acta 2003;331:79-85.
25. Musumeci M, Simpore J, Barone R, Angius A, Musumeci S. Synchronic macrophage response and Plasmodium falciparum malaria. J Vect Borne Dis 2006;43:84-7.
26. Malaguarnera L, Pignatelli S, Musumeci M, Simpore J, Musumeci S. Plasma levels of interleukin-18 and interleukin-12 in Plasmodium falcipartan malaria. Parasite Immunol. 2002;24: 489-92.
27. Meraitou M, Dimitriou E, Michelakakis H. Iron load and chitotrinsidase activity in rat tissues (Abstract). Meeting of the second Working Group of Gaucher's Disease, Maastricht, May 1-3,1997
28. Malaguarnera L, Musumeci M, Di Rosa M, Scuto A, Musumeci S. Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal. 2005;19:128-32.
29. Di Luca M, Romi I, Severini F, Toma L, Musumeci M, Fausto AM, Mazzini M, Gambellini G, Musumeci S. Human chitotriosidase helps Plasmodium falciparum in the midgut of Anopheles. J Vect Borne Dis 2006;43:144-146
30. Villalon JM, Ghosh A, Jacobs-Lorena M. The peritrophic matrix limits the rate of digestion in adult Anopheles stephensi and Aedes aegypti mosquitoes. J Insect Physiol. 2003;49:891-5.
31. Filho BP, Lemos FJ, Secundino NF, Pascoa V, Pereira ST, Pimenta PF. Presence of chitinase and beta-N-acetylglucosaminidase in the Aedes aegypti. A chitinolytic system involving peritrophic matrix formation and degradation. Insect Biochem Mol Biol. 2002;32:1723-9.
32. Droge W. The plasma redox state and ageing. Ageing Res Rev. 2002;1:257-78
33. Van Remmen H, Richardson A. Oxidative damage to mitochondria and aging. Exp Gerontol. 2001;36:957-68
34. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM, de Vries CJ. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol. 1999;19:687-94.
35. Artieda M, Cenarro A, Ganan A, Jerico I, Gonzalvo C, Casado JM, Vitoria I, Puzo J, Pocovi M, Civeira F. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol. 2003;23:1645-52.
36. Brizzi P, Tonolo G, Bertrand G, Carusillo F, Severino C, Maioli M, Malaguarnera L, Musumeci S. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status. Clin Chem Lab Med. 2004;42:164-70.
37. Roselaar SE, Schonfeld G, Daugherty A Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest. 1995;96(3):1389-94.
38. Sotgiu S, Piras MR, Barone R, Arru G, Fois ML, Rosati G and Musumeci S. Chitotriosidase and Alzheimer's disease. Curr Alzheimer Res. 2007; 4 (1): in press
39. Lue LF, Kuo YM, Roher AE, Brachova L. et al. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 2006;155:853-62.
40. Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci. 2002;202(1-2):13-23
41. Di Rosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci 2006;23:2648-56.
42. Castellani RJ, Siedlak SL, Fortino AE, Perry G, Ghetti B, Smith MA. Chitin-like polysaccharides in Alzheimer's disease brains. Curr Alzheimer Res. 2005;2(4):419-23.
43. Zhang GX, Yu S, Gran B, Rostami A. Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J Immunology 175:7202-7208 (2005).
44. Rothwell NJ, Loddick SA, Stroemer P. Interleukins and cerebral ischaemia. Int Rev Neurobiol. 1997;40:281-98.
45. Castillo J, Rodriguez I: Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004;17(Suppl. 1):7-18.
46. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arm A, Pirisi A, Rosati G. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol. 2006;13(5):505-13.
47. Palasik W, Fiszer U, Lechowicz W, Czartoryska B, Krzesiewicz M, Lugowska A: Assessment of relations between clinical outcome of ischemic, stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. Eur Neurol 2005;53:188-193.
48. Sotgiu S, Barone R, Zanda B, Arru G, Fois ML, Arm A, Rosati G, Marchetti B, Musumeci S. Chitotriosidase in patients with acute ischemic stroke. Eur Neurol 2005;54:149-53.
49. Corcione A, Casazza S, Ferretti E, Giumi D, Zappia E, Pistorio A, Gambini C, Mancardi GL, Uccelli A, Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A. 2004;101:11064-9.
50. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of MS lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000;47:707-17.
51. Kornek B and Lassmann H. Neuropathology of multiple sclerosis: new concepts. Brain Research Bulletin 2003;61:321-26.
52. Hendriks JA, Teunissen CE, de Vries HE, Dijkstra CD. Macrophages and neurodegeneration. Brain Research Reviews 2005; 49:185-95.
53. Sotgiu S, Barone R, Arru G, Fois ML, Pugliatti M, Sanna A, Rosati G, Musumeci S. Intrathecal chitotriosidase and the outcome of multiple sclerosis. Mult Scler 2006;12:551-557.
54. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33: 1444-52.
55. Trapp BD, B6 L, M6rk S, Chang A. Pathogenesis of tissue injury in MS lesions. J Neuroimmunol 1999;98:49-56.
56. Guo Y, He W, Boer AM et al: Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inher Metab Dis 1995;18:717-22.
57. Stirnemann J, Caubel I, Kettaneh A, Fain O, Belmatoug N. Epidemiologic, clinical, biological and therapeutic aspects of Gaucher's disease. Presse Med. 2003;32(11):503-11